SB 220025

Description

SB 220025 is a reversible, orally active, cell-permeable, ATP-competitive and selective human p38 MAPK inhibitor IC50 = 60 nM . SB 220025 also inhibits p56Lck and PKC with IC50 values of 3.5 and 2.89 AAasAasAAmuM, respectively. SB 220025 inhibits the expression of IL-8 gene in response to globular adiponectin gAd , reduces inflammatory cytokine production and inhibits angiogenesis. SB 220025 effectively prevents the progression of arthritis in a chronic inflammatory disease model and can be used in the study of inflammation.